Generics The president & CEO of Canada’s largest generics player considers the current market dynamics for generic products, including IP regulation, generic penetration, and the advantages of balancing branded and non-branded products. What was the strategy behind the integration of Novopharm into Teva? Novopharm is one of the pioneers in the…
See our Cookie Privacy Policy Here